A股異動丨奇德新材跌超10% 年度毛利率和淨利率出現下滑
奇德新材(300995.SZ)下跌超10%,股價再度失守30元關口,總市值23.4億元。消息上,公司日前公吿,24年實現營業總收入3.46億元,同比增長22.20%;歸母淨利潤868.7萬元,同比增長8.13%;這些數據顯示公司在過去一年中實現了較為穩健的增長。儘管公司整體收入有所增長,但毛利率和淨利率卻出現了下滑。2024年毛利率為22.8%,同比減少了14.46個百分點;淨利率為2.55%,同比減少了9.86個百分點。這表明公司在成本控制方面面臨一定挑戰。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.